Thomas Ryll
Vice President of Technical Operations, Immunogen
Meet Thomas Ryll
Thomas was highly commended by the judging panel for his dedication to industry and innovation, particularly in antibody drug conjugates. He has over 24 years of experience in bioprocessing, having worked for Genentech (where he was part of the first generation of large scale manufacturing processes for antibodies and recombinant proteins), Abgenix, Tanox, and Biogen, prior to Immunogen.